Predictors for the white coat effect in general practice patients with suspected and treated hypertension

被引:0
|
作者
Lindbæk, M
Sandvik, E
Liodden, K
Mjell, J
Ravnsborg-Gjertsen, K
机构
[1] Univ Oslo, Dept Gen Practice & Community Med, N-0318 Oslo, Norway
[2] Stovner Hlth Care Ctr, Oslo, Norway
[3] Stokke Doctors Ctr, Stokke, Norway
关键词
ambulatory blood pressure monitoring; white coat hypertension; hypertension;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Ambulatory blood pressure monitoring was introduced more than 40 years ago and is accepted as a clinically useful method to evaluate the white coat effect in patients with suspected and established hypertension. Aim. To study the differences between blood pressure readings taken in the physician's office in the primary healthcare setting, and ambulatory readings, and to find possible predictors Design of study Prospective study Setting. Two primary healthcare centres in Norway Method: The study included 221 patients, 107 of whom were on antihypertensive treatment, and 114 of whom were under investigation for possible hypertension. Differences between blood pressure readings taken in the physician's office and ambulatory readings were calculated Independent predictors for the white coat effect were calculated using linear regression analysis. Results. The difference between blood pressure readings taken in the office and ambulatory readings was 2 7 mmHg systolic and I I mmHg diastolic. For the systolic readings, the following factors were independent predictors of the amount of the white coat effect. mean blood pressure, age, history of smoking family history of cardiovascular disease, and antihypertensive treatment. For the diastolic readings, they were. mean blood pressure, history of smoking, and sex of the patient (with this being most significant for women). Conclusion: Ambulatory blood pressure measurement is of significant value in identifying patients with white coat hypertension. It can be an important supplement for use in the diagnosis and follow-up of patients with hypertension in general practice.
引用
收藏
页码:790 / 793
页数:4
相关论文
共 50 条
  • [1] White coat effect and white coat hypertension in pediatric patients
    Matsuoka, S
    Kawamura, K
    Honda, M
    Awazu, M
    PEDIATRIC NEPHROLOGY, 2002, 17 (11) : 952 - 955
  • [2] White coat effect and white coat hypertension in community pharmacy practice
    Botomino, A
    Martina, B
    Ruf, D
    Bruppacher, R
    Hersberger, KE
    BLOOD PRESSURE MONITORING, 2005, 10 (01) : 13 - 18
  • [3] White coat effect in patients with hypertension
    Andreeva, G. F.
    Gorbunov, V. M.
    Antipushina, D. N.
    Platonova, E., V
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (05) : 508 - 519
  • [4] Independent predictors of isolated clinic ('white-coat') hypertension
    Verdecchia, P
    Palatini, P
    Schillaci, G
    Mormino, P
    Porcellati, C
    Pessina, AC
    JOURNAL OF HYPERTENSION, 2001, 19 (06) : 1015 - 1020
  • [5] WHITE COAT HYPERTENSION AND WHITE COAT EFFECT - SIMILARITIES AND DIFFERENCES
    VERDECCHIA, P
    SCHILLACI, G
    BORGIONI, C
    CIUCCI, A
    ZAMPI, I
    GATTOBIGIO, R
    SACCHI, N
    PORCELLATI, C
    AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (08) : 790 - 798
  • [6] Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study
    Sabater-Hernandez, Daniel
    Sanchez-Villegas, Pablo
    Garcia-Corpas, Jose P.
    Amariles, Pedro
    Sendra-Lillo, Jose
    Faus, Maria J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (03) : 582 - 589
  • [7] White coat hypertension in a general practice - prevalence, cardiovascular risk factors and clinical implications
    Sandvik, E
    Steine, S
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 1998, 16 (04) : 222 - 226
  • [8] Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study
    Daniel Sabater-Hernández
    Pablo Sánchez-Villegas
    José P. García-Corpas
    Pedro Amariles
    José Sendra-Lillo
    María J. Faus
    International Journal of Clinical Pharmacy, 2011, 33
  • [10] White coat hypertension in type 1 diabetic patients without nephropathy
    Flores, L
    Recasens, M
    Gomis, R
    Esmatjes, E
    AMERICAN JOURNAL OF HYPERTENSION, 2000, 13 (05) : 560 - 563